An interventional study of Body-Based Regulation Program and Mind-Based Regulation Program in Overweight and/or Obesity, sponsored by Pamukkale University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 353 studies in Obesity with a site in Turkey — 73 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.
Among the 353 studies in Obesity with a site in Turkey, this one is the 167th largest by planned enrollment of the 192 interventional ones that give a count, is one of 60 that started in 2026, is one of 161 with no phase, reaches primary completion later than 63 of the 89 other live ones, and was the 305th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →73 of the 353 studies in Obesity with a site in Turkey are open now. Recruiting first, the newest first:
Pamukkale University · Sites in Turkey
Ages 18–65 · Women only
Gazi University · Sites in Turkey
Ages 50–60 · Women only
Duzce University · Sites in Turkey
Ages 18+
Pamukkale University · Sites in Turkey
Ages 18–60 · Women only
Kocaeli University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 60 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
353 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 27 · Phase 4 3
First in 2005; this study’s year is marked. 60 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 64 across the 192 interventional studies, 82 across the 160 observational. Of the 237 that completed or were terminated, 7 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
34 of 353 have an industry lead sponsor. The 10 most frequent:
Pamukkale University is the lead sponsor of 343 studies on the registry; 61 are open to participants now.
Pamukkale University has 9 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
33 of the studies in Obesity with a site in Turkey that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05556512Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | 2027-10 |
| NCT07769736Istinye UniversityMotivational Interviews Based on the Five-Step (5A) Model on Obesity Risk | 2026-11 |
| NCT07652151Fundación Pública Andaluza para la gestión de la Investigación en SevillaUNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers | 2026-11 |
| NCT07846956Istanbul Saglik Bilimleri UniversityNAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study | 2026-11-30 |
| NCT07858864Istanbul Saglik Bilimleri UniversityGLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes | 2026-11-30 |
Add all 33 to your calendar (.ics) → With an account.
Among the 353 studies in Obesity with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will compare two regulation-based approaches in women with overweight or obesity. The first approach is a body-based regulation program including breathing awareness, body-awareness-based yoga practices, non-invasive manual auricular stimulation, and restorative relaxation. The second approach is a mind-based regulation program including structured psychoeducation and cognitive-emotional awareness activities focused on stress, emotions, automatic thoughts, and emotional eating.
Participants will be women aged 18 to 60 years with a body mass index between 27.0 and 39.9 kg/m². Eligible participants will be randomly assigned to one of the two intervention groups. Both programs will last 8 weeks.
The main aim of the study is to examine and compare the preliminary effects of these two approaches on heart rate variability, especially RMSSD, which is an indicator of cardiac vagal regulation. The study will also assess emotional eating, self-compassion, mindfulness, body measurements, body composition, adherence to the program, and possible adverse events. Assessments will be performed at baseline and after the 8-week intervention by an evaluator who is blinded to group allocation.
Overweight and obesity are associated not only with metabolic and physical health problems but also with changes in autonomic nervous system regulation, emotional eating, and psychological well-being. Reduced heart rate variability may reflect impaired cardiac vagal regulation and may be related to stress-related and emotion-related eating behaviors. Regulation-based approaches that target either body-to-mind or mind-to-body pathways may provide supportive strategies for improving autonomic and emotional regulation in women with overweight or obesity.
This study is designed as a two-arm, parallel-group, evaluator-blinded randomized trial. The study population will consist of women aged 18 to 60 years with overweight or obesity who apply to the Exercise and Obesity Unit of the Faculty of Physiotherapy and Rehabilitation, Pamukkale University. Participants will be randomized in a 1:1 ratio using BMI-category-stratified block randomization based on a computer-generated allocation sequence prepared by a researcher who is not involved in outcome assessment or intervention delivery. Allocation will be concealed until the baseline assessment is completed. The evaluator who performs baseline and post-intervention assessments will remain blinded to group allocation.
The Body-Based Regulation Group will receive an 8-week structured program delivered face-to-face by a physiotherapist. The program will include breathing awareness, body-awareness-based yoga practices, non-invasive manual auricular stimulation, and restorative relaxation. Sessions will be conducted twice weekly for 8 weeks, with each session lasting approximately 60 minutes. This intervention is intended to support autonomic and cardiac vagal regulation through body-based mechanisms.
The Mind-Based Regulation Group will receive an 8-week structured psychoeducation and cognitive-emotional awareness program. The program will focus on recognizing the relationships among stress, emotional states, automatic thoughts, and eating behavior; identifying triggers for emotional eating; developing more balanced cognitive responses; and creating alternative behavioral strategies for eating urges. Face-to-face structured sessions will be conducted in weeks 1, 4, and 8. In the remaining weeks, participants will receive standardized digital content and study forms and will attend short online meetings. The weekly module duration will be approximately 30 to 45 minutes. This intervention will not include yoga, breathing exercises, relaxation exercises, or other body-based practices.
Assessments will be conducted at baseline and after the 8-week intervention. Heart rate variability will be the primary physiological outcome. RR interval data will be recorded using a Polar H10 chest strap after a 10-minute quiet adaptation period, followed by a 5-minute resting recording. RMSSD will be the primary HRV parameter. If required according to distributional characteristics, RMSSD values will be analyzed after natural logarithmic transformation as lnRMSSD. Secondary HRV parameters will include HF, LF/HF, SDNN, and mean heart rate.
Patient-reported outcomes will include emotional eating, eating behavior, self-compassion, and mindfulness. Anthropometric measurements and body composition will be recorded as exploratory and descriptive outcomes. Adherence to the intervention, completion of home/module-related activities, and possible adverse events will also be monitored throughout the study.
The primary analysis will compare post-intervention RMSSD or lnRMSSD values between groups using an analysis of covariance model adjusted for baseline values. Secondary outcomes will be analyzed using similar baseline-adjusted models where appropriate. The study is planned to include 30 participants in total, with 15 participants in each group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to this arm will receive an 8-week body-based regulation program delivered by a physiotherapist. The intervention aims to improve body awareness, autonomic regulation, and emotional regulation. Outcome assessments will be conducted at baseline and at the end of the intervention.
Behavioral: Body-Based Regulation Program
Participants assigned to this arm will receive an 8-week mind-based regulation program consisting of structured psychoeducation and cognitive-emotional awareness practices. Outcome assessments will be conducted at baseline and at the end of the intervention.
Behavioral: Mind-Based Regulation Program
Participants will receive an 8-week structured body-based regulation program administered by a physiotherapist. The program consists of 16 supervised face-to-face sessions (twice weekly, 60 minutes each) including breathing awareness exercises, body awareness-based yoga practices, non-invasive manual auricular stimulation, and restorative relaxation techniques. The intervention is designed to improve body awareness, autonomic nervous system regulation, and emotional regulation.
Participants will receive an 8-week structured psychoeducation and cognitive-emotional awareness program developed by a clinical psychologist. The intervention aims to improve awareness of the relationships among stress, emotions, automatic thoughts, and eating behavior, recognize emotional eating triggers, develop balanced cognitive responses, and strengthen adaptive coping strategies. The program includes face-to-face sessions during weeks 1, 4, and 8, standardized digital educational materials, weekly online follow-up meetings, and self-monitoring exercises. No yoga, breathing exercises, relaxation exercises, or body-based practices are included.
Heart Rate Variability (RMSSD)
RMSSD (ms) will be derived from a 5-minute resting RR-interval recording obtained using a Polar H10 chest strap and analyzed using Kubios HRV software. If required based on distributional characteristics, RMSSD values will be natural-log transformed and analyzed as lnRMSSD.
Time frame: Baseline and Week 8
High-Frequency Power (HF)
Change in high-frequency (HF) power (ms²), an index of parasympathetic cardiac autonomic activity derived from heart rate variability recordings.
Time frame: Baseline and Week 8
Low Frequency/High Frequency Ratio (LF/HF Ratio)
Change in the low frequency/high frequency (LF/HF) ratio derived from heart rate variability recordings.
Time frame: Baseline and Week 8
Standard Deviation of NN Intervals (SDNN)
Change in the standard deviation of normal-to-normal intervals (SDNN, ms), a time-domain heart rate variability parameter reflecting overall autonomic variability.
Time frame: Baseline and Week 8
Mean Heart Rate
Change in resting mean heart rate (beats per minute \[bpm\]) measured during the heart rate variability assessment.
Time frame: Baseline and Week 8
Eating Behavior (Dutch Eating Behavior Questionnaire, DEBQ)
Eating behavior will be assessed using the validated Turkish version of the 33-item Dutch Eating Behavior Questionnaire (DEBQ). The questionnaire comprises three subscales assessing emotional eating, external eating, and restrained eating. Items are rated on a 5-point Likert scale ranging from "never" to "very often," with an additional "not applicable" response option where appropriate. Scores for the emotional eating, external eating, and restrained eating subscales will be calculated and analyzed separately according to the validated scoring instructions. Higher scores on each subscale indicate a greater tendency toward the corresponding eating behavior.
Time frame: Baseline and Week 8
Emotional Eating (Turkish Emotional Eating Scale)
Emotional eating will be assessed using the 30-item Turkish Emotional Eating Scale. Each item is rated on a 5-point Likert scale ranging from 1 ("never") to 5 ("almost always"). The scale evaluates the tendency to eat in response to emotional states and related difficulties in controlling eating behavior. A total score is calculated by summing the item scores, with possible scores ranging from 30 to 150. Higher scores indicate a greater tendency toward emotional eating.
Time frame: Baseline and Week 8
Self-Compassion
Self-compassion will be assessed using the validated Turkish version of the 24-item Self-Compassion Scale. The scale evaluates how individuals respond to themselves during difficult or distressing experiences. Items are rated on a 5-point Likert scale ranging from "almost never" to "almost always." Negatively worded items will be reverse-scored according to the validated scoring instructions. A total score will be calculated, with higher scores indicating greater self-compassion.
Time frame: Baseline and Week 8
Mindfulness
Mindfulness will be assessed using the validated Turkish version of the 15-item Mindful Attention Awareness Scale (MAAS). The scale evaluates an individual's general tendency to attend to and remain aware of present-moment experiences in daily life. Items are rated on a 6-point Likert scale ranging from "almost always" to "almost never." A single overall score will be calculated according to the validated scoring instructions. Higher scores indicate greater mindful awareness.
Time frame: Baseline and Week 8
Protocol Adherence
The percentage of prescribed intervention components completed will be recorded. In the Body-Based Regulation Group, adherence will be calculated based on attendance at the 16 supervised face-to-face sessions. In the Mind-Based Regulation Group, adherence will be calculated based on completion of weekly modules, digital content, brief online meetings, and study forms. Participants completing at least 80% of the prescribed intervention components will be classified as protocol completers.
Time frame: Through Week 8
Participants With Intervention-Related Adverse Events
The number and type of symptoms, unexpected health problems, and adverse events occurring during or after the interventions and considered possibly related to the intervention will be recorded.
Time frame: Through Week 8
Body Weight
Change in body weight measured in kilograms using a calibrated digital scale
Time frame: Baseline and Week 8
Body Mass Index (BMI)
Change in body mass index (kg/m²) calculated as weight in kilograms divided by height in meters squared.
Time frame: Baseline and Week 8
Waist Circumference
Change in waist circumference (cm) measured using a non-stretch measuring tape.
Time frame: Baseline and Week 8
Hip Circumference
Change in hip circumference (cm) measured using a non-stretch measuring tape.
Time frame: Baseline and Week 8
Waist-to-Hip Ratio
Change in waist-to-hip ratio calculated from waist and hip circumference measurements.
Time frame: Baseline and Week 8
Body Fat Percentage
Change in body fat percentage (%) measured using bioelectrical impedance analysis (Tanita BC-418).
Time frame: Baseline and Week 8
Muscle Mass
Change in muscle mass (kg) measured using bioelectrical impedance analysis (Tanita BC-418).
Time frame: Baseline and Week 8
Fat-Free Mass
Change in fat-free mass (kg) measured using bioelectrical impedance analysis (Tanita BC-418).
Time frame: Baseline and Week 8
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 8 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.